FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 巨子生物控股有限公司 呈交日期： 2026年1月14日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關 ...

Group 1 - The article discusses the share buybacks conducted by various companies on January 13, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.012 million shares [1][2] - Other notable companies involved in the buyback include Xiaomi Group (01810) with 4 million shares repurchased for 152 million yuan, and Sunny Optical Technology (02382) with 640,000 shares for approximately 41.79 million yuan [1][2] - The total number of shares repurchased by Tencent Holdings in the year reached 11 million, representing 1.199% of its total share capital [2] Group 2 - The buyback activities reflect a strategic move by companies to enhance shareholder value and signal confidence in their financial health [1][2] - Companies like Weigao Group (01066) and Xinli International (00732) also showed significant buyback activity, with Weigao repurchasing 27,440 shares for 1.4962 million yuan, representing 6.519% of its total share capital [2] - The data indicates a trend among companies to engage in share buybacks as a method to return capital to shareholders and potentially boost stock prices [1][2][3]

研究报告 Research Report 14 Jan 2026 首次覆盖：重组胶原蛋白领军者，2026 战略转型开启品牌化新篇章 Recombinant Collagen Leader: 2026 Strategy Ushers in Brand New Era: Initiation [Table_yemei1] 观点聚焦 Investment Focus [Table_Info] 首次覆盖优于大市 Initiate with OUTPERFORM 评级 优于大市 OUTPERFORM 现价 HK$35.74 目标价 HK$43.60 HTI ESG 3.1-3.9-4.0 E-S-G: 0-5, (Please refer to the Appendix for ESG comments) 市值 HK$38.27bn / US$4.91bn 日交易额 (3 个月均值) US$58.76mn 发行股票数目 1,071mn 自由流通股 (%) 45% 1 年股价最高最低值 HK$84.90-HK$33.28 注：现价 HK$35.74 为 2026 年 01 月 13 日收盘价 资料来源： Factset ...

巨子生物(02367.HK)1月13日耗资1433.8万港元回购40万股 巨子生物(02367.HK)1月12日耗资1400万港元 回购40万股 相关事件 格隆汇1月13日丨巨子生物(02367.HK)公告，1月13日耗资1433.8万港元回购40万股，每股回购价35.64- 36.2港元。 ...

巨子生物(02367)发布公告，于2026年1月13日斥资1433.78万港元回购40万股。 ...

智通财经APP讯，巨子生物(02367)发布公告，于2026年1月13日斥资1433.78万港元回购40万股。 ...

第 1 頁 共 8 頁 v 1.3.0 | 1). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 35.941 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年12月9日 | | | | | | 2). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 35.956 | | | 變動日期 | 2025年12月10日 | | | | | | 3). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 34.7189 | | | 變動日期 | 2025年12月11日 | | | | | | 4). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 35.0909 | | | 變動日期 | 2025年12月12日 | | | | | | 5). | 購回股份擬註銷但尚未註銷 | | 400,000 | 0.0374 % | HKD | 34.7931 | | | 變動日期 ...

Group 1 - The article reports on share buybacks conducted by various companies on January 12, 2026, with Tencent Holdings (00700) having the largest buyback amount of 636 million yuan for 1.024 million shares [1][2] - Other notable companies involved in the buyback include Geely Automobile (00175) with 9.007 million shares repurchased for 151 million yuan, and Sunny Optical Technology (02382) with 1.24 million shares for 79.34 million yuan [1][2] - The total number of shares repurchased by Tencent represents 1.188% of its total share capital, while Geely's buyback accounts for 0.438% of its total share capital [2] Group 2 - The buyback activities reflect a trend among companies to return capital to shareholders, with some companies like Antong Oilfield Services (03337) and Weigao Group (01066) showing significant percentages of their total share capital being repurchased, at 2.460% and 6.459% respectively [2][3] - Companies such as Vitasoy International (00345) and Keep (03650) also participated in the buyback, with their repurchase amounts being 432,600 yuan and 28,900 yuan respectively, indicating a diverse range of companies engaging in this practice [3] - The data suggests a strategic move by these companies to enhance shareholder value and potentially stabilize their stock prices amid market fluctuations [1][2]

巨子生物(02367)发布公告，于2026年1月12日，该公司斥资1400.29万港元回购40万股股份，每股回购价 格为34.5-35.5港元。 ...

智通财经APP讯，巨子生物(02367)发布公告，于2026年1月12日，该公司斥资1400.29万港元回购40万股 股份，每股回购价格为34.5-35.5港元。 ...